Skip to content

AIGH CAPITAL MANAGEMENT, LLC

AIGH CAPITAL MANAGEMENT, LLC is a Series C+ and buyout fund in the US investing in healthcare-tech, biopharmaceutical, drug-discovery and biotechnology.

Stages
Series C+, buyout
Sectors
healthcare-tech, biopharmaceutical, drug-discovery, biotechnology
Invests in
US-wide
Founded
2011
Assets under management
$472.7M

Check size not disclosed

Thesis

AIGH Capital Management, LLC is a private equity firm founded in 2011, headquartered in Baltimore, Maryland. The firm specializes in 'Value turning to Growth' investment situations, aiming to generate attractive returns by identifying undervalued companies with reaccelerating revenue and earnings, and low Wall Street expectations. Their strategy involves deep engagement with companies and thorough fundamental research. While diversified, the Health Care sector is their most substantial focus (42.6%), with a recent repositioning towards biopharmaceuticals, drug discovery, and biotechnology. They also engage in private placements in high-technology companies. As of December 31, 2025, their AUM was approximately $472,733,684, with a 13F portfolio value of $733.22 million as of March 31, 2026. The firm is described as a PE/Buyout firm with a focus on Growth/Expansion stages. The typical check size per investment is not publicly disclosed.

Common questions

Does AIGH CAPITAL MANAGEMENT, LLC invest at the Series C+ stage?

Yes. AIGH CAPITAL MANAGEMENT, LLC lists Series C+ and buyout among the stages it invests in.

Where does AIGH CAPITAL MANAGEMENT, LLC invest?

AIGH CAPITAL MANAGEMENT, LLC invests in the US.